Review ArticleReview Article
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Philippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. Brotchie
David R. Sibley, ASSOCIATE EDITOR
Pharmacological Reviews January 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
Philippe Huot
Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada (P.H., T.H.J, J.B.K, S.H.F., J.M.B.); and Division of Neurology, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (P.H., S.H.F.)
Tom H. Johnston
Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada (P.H., T.H.J, J.B.K, S.H.F., J.M.B.); and Division of Neurology, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (P.H., S.H.F.)
James B. Koprich
Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada (P.H., T.H.J, J.B.K, S.H.F., J.M.B.); and Division of Neurology, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (P.H., S.H.F.)
Susan H. Fox
Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada (P.H., T.H.J, J.B.K, S.H.F., J.M.B.); and Division of Neurology, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (P.H., S.H.F.)
Jonathan M. Brotchie
Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada (P.H., T.H.J, J.B.K, S.H.F., J.M.B.); and Division of Neurology, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (P.H., S.H.F.)
David R. Sibley
Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada (P.H., T.H.J, J.B.K, S.H.F., J.M.B.); and Division of Neurology, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (P.H., S.H.F.)
Roles: ASSOCIATE EDITOR
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Review ArticleReview Article
l-DOPA-Induced Dyskinesia Pharmacology
Philippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. Brotchie
Pharmacological Reviews January 1, 2013, 65 (1) 171-222; DOI: https://doi.org/10.1124/pr.111.005678
Jump to section
- Article
- Abstract
- I. Introduction
- II. Review Terms of Reference and Presentation
- III. The Classic Model of the Functional Organization of the Basal Ganglia
- IV. The Dopaminergic System
- V. The Glutamatergic System
- VI. The Opioid System
- VII. The Serotonergic System
- VIII. The GABAergic System
- IX. The Adenosine System
- X. Cannabinoid Neurotransmission
- XI. Adrenergic Neurotransmission
- XII. Histaminergic Neurotransmission
- XIII. Cholinergic Neurotransmission
- XIV. Tachykinin Neurotransmission
- XV. Transcription Factors and Intracellular Signaling
- XVI. Emerging Concepts in Dyskinesia
- XVII. Concluding Remarks
- Authorship contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement